Cargando…

Impact of Adherence to Ibrutinib on Clinical Outcomes in Real-World Patients With Chronic Lymphocytic Leukemia

BACKGROUND: Chronic lymphocytic leukemia (CLL) is a B-cell neoplasm with clonal expansion of small lymphocytes. Ibrutinib, an irreversible inhibitor of Bruton tyrosine kinase (BTK), is a first-line treatment option, and recent data suggest that strict adherence is directly related to clinical outcom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garner, Lauren M., Kline, Theresa, Miller, Jordan, Deal, Allison, Zhu, Anqi, Sketch, Margaret R., Coombs, Catherine C., Muluneh, Benyam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Harborside Press LLC 2021
Materias:	Research & Scholarship
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844188/ https://www.ncbi.nlm.nih.gov/pubmed/33552659 http://dx.doi.org/10.6004/jadpro.2021.12.1.2

Ejemplares similares

A Pharmacist-Led Oral Chemotherapy Program's Impact on Chronic Myeloid Leukemia Patient Satisfaction, Adherence, and Outcomes
por: Dennison, Taylor, et al.
Publicado: (2021)

Understanding Barriers to Oral Therapy Adherence in Adults With Acute Myeloid Leukemia
por: Bryant, Ashley Leak, et al.
Publicado: (2020)

Characteristics of Distress and Support Group Participation in Caregivers of Older Allogeneic Hematopoietic Cell Transplantation Patients: A Single Institution Retrospective Review
por: Elko, Theresa A., et al.
Publicado: (2023)

Adherence to Prophylactic Anticonvulsant Guidelines for Newly Diagnosed Brain Tumor Patients: A Quality Improvement Study
por: Fu, Dan Beverly, et al.
Publicado: (2022)

Silent Conversations: Goals of Care and End-of-Life Quality in Relapsed High-Risk Leukemia
por: Graham, Lacy Jo, et al.
Publicado: (2023)

Real-world comparative effectiveness of acalabrutinib and ibrutinib in patients with chronic lymphocytic leukemia
por: Roeker, Lindsey E., et al.
Publicado: (2023)

Research Strategy for the Development of a Quality-of-Life Decision-Making Model for Older Patients With Acute Myeloid Leukemia
por: Tinsley-vance, Sara M.
Publicado: (2023)

Real-World Comparison of First-Line Treatment Adherence Between Single-Agent Ibrutinib and Acalabrutinib in Patients with Chronic Lymphocytic Leukemia
por: Lu, Xiaoxiao, et al.
Publicado: (2023)

Overcoming Ibrutinib Resistance in Chronic Lymphocytic Leukemia
por: Puła, Bartosz, et al.
Publicado: (2019)

Bone Reconstruction in Chronic Lymphocytic Leukemia with Ibrutinib
por: Koba, Yusuke, et al.
Publicado: (2023)

Concomitant imatinib and ibrutinib in a patient with chronic myelogenous leukemia and chronic lymphocytic leukemia
por: Shea, Lauren K., et al.
Publicado: (2017)

Current Testing Guidelines: A Retrospective Analysis of a Community-Based Hereditary Cancer Program
por: Ward, Margaret, et al.
Publicado: (2021)

Hypertension in Patients Treated With Ibrutinib for Chronic Lymphocytic Leukemia
por: Roeker, Lindsey E., et al.
Publicado: (2019)

Ibrutinib-Induced Cardiac Tamponade in Chronic Lymphocytic Leukemia
por: Kidoguchi, Keisuke, et al.
Publicado: (2021)

Development and Implementation of an Advanced Practitioner–Led Survivorship Clinic for Patients Status Post Allogeneic Transplant
por: Baer, Linda k., et al.
Publicado: (2021)

Clinical indicators of acute deterioration in persons who reside in residential aged care facilities: A rapid review
por: Chambers, Shirley, et al.
Publicado: (2022)

Pharmacists’ Role in Managing Patients with Chronic Lymphocytic Leukemia
por: Chen, Kevin Y., et al.
Publicado: (2020)

Response to ibrutinib in chronic lymphocytic leukemia improves in quality with time
por: Molica, Stefano, et al.
Publicado: (2016)

Invasive aspergillosis related to ibrutinib therapy for chronic lymphocytic leukemia
por: Arthurs, Benjamin, et al.
Publicado: (2017)

Cutaneous mucormycosis in a chronic lymphocytic leukemia patient on ibrutinib
por: Sittig, Katherine R., et al.
Publicado: (2021)

Effects of ibrutinib on T-cell immunity in patients with chronic lymphocytic leukemia
por: Liu, Yanyan, et al.
Publicado: (2022)

Outcomes with ibrutinib by line of therapy and post‐ibrutinib discontinuation in patients with chronic lymphocytic leukemia: Phase 3 analysis
por: O'Brien, Susan M., et al.
Publicado: (2019)

Real-world Clinical Outcomes of First-Line Ibrutinib or Chemoimmunotherapy in Patients with Chronic Lymphocytic Leukemia by Risk Status
por: Huang, Qing, et al.
Publicado: (2022)

Effectiveness and Safety of Ibrutinib for Chronic Lymphocytic Leukemia in Routine Clinical Practice: 3-Year Follow-up of the Belgian Ibrutinib Real-World Data (BiRD) Study
por: Janssens, Ann, et al.
Publicado: (2022)

Systematic Literature Review of Real-World Effectiveness Results Data for First-Line Ibrutinib in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
por: Lee, Philip, et al.
Publicado: (2022)

Ibrutinib in Relapsed or Refractory Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia
por: Peterson, Derek, et al.
Publicado: (2014)

Disseminated Cryptococcal Disease in a Patient with Chronic Lymphocytic Leukemia on Ibrutinib
por: Okamoto, Koh, et al.
Publicado: (2016)

The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy
por: Landau, Dan A., et al.
Publicado: (2017)

Amebic Encephalitis in a Patient with Chronic Lymphocytic Leukemia on Ibrutinib Therapy
por: Voshtina, Ensi, et al.
Publicado: (2018)

Cranial aspergillosis in a patient receiving ibrutinib for chronic lymphocytic leukemia
por: Beresford, Rohan, et al.
Publicado: (2019)

Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia
por: Fiorcari, Stefania, et al.
Publicado: (2016)

Progressive Multifocal Leukoencephalopathy after Ibrutinib Therapy for Chronic Lymphocytic Leukemia
por: Lutz, Mathias, et al.
Publicado: (2017)

Spotlight on ibrutinib and its potential in frontline treatment of chronic lymphocytic leukemia
por: Khan, Maliha, et al.
Publicado: (2017)

Ibrutinib in Chronic Lymphocytic Leukemia: Clinical Applications, Drug Resistance, and Prospects
por: Zhou, Hong, et al.
Publicado: (2020)

Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib
por: Hampel, Paul J., et al.
Publicado: (2022)

“In Our Own Little World”: Invisibility of the Social and Ethical Dimension of Engineering Among Undergraduate Students
por: Lim, Jae Hoon, et al.
Publicado: (2021)

Real-world experience of ibrutinib therapy in relapsed chronic lymphocytic leukemia: results of a single-center retrospective analysis
por: Nuttall, Elisabeth, et al.
Publicado: (2019)

Benefits of Teaching Medical Students How to Communicate with Patients Having Serious Illness: Comparison of Two Approaches to Experiential, Skill-Based, and Self-Reflective Learning
por: Ellman, Matthew S., et al.
Publicado: (2012)

Creating a Surgery Clerkship in a Changing Environment: Reality, Simulation, and the Rules of Engagement
por: Evans, Leigh V., et al.
Publicado: (2012)

How to Learn Effectively in Medical School: Test Yourself, Learn Actively, and Repeat in Intervals
por: Augustin, Marc
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_b064rq6tde3niosspgksdoomhf